Global Natural Killer Cell Therapeutics Market by Therapeutics (NK Cell Directed Antibodies, NK Cell Therapies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application, End User - Forecast 2024-2030- Product Image

Sale

Global Natural Killer Cell Therapeutics Market by Therapeutics (NK Cell Directed Antibodies, NK Cell Therapies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application, End User - Forecast 2024-2030

Report
184 Pages
March 2024
Region: Global
360iResearch™
ID: 5925190

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Natural Killer Cell Therapeutics Market size was estimated at USD 5.31 billion in 2023, USD 6.02 billion in 2024, and is expected to grow at a CAGR of 11.94% to reach USD 11.71 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Natural Killer Cell Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Natural Killer Cell Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Natural Killer Cell Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Acepodia Inc., Affimed N.V., BioHaven Pharmaceutical Holding Company Ltd. by Pfizer Inc., Celgene Corporation by Bristol-Myers Squibb Company, Celularity Inc., Century Therapeutics, Inc., Cytovac A/S, Dragonfly Therapeutics, Inc., EMERcell, Fate Therapeutics, Inc., Fortress Biotech, Inc., Gamida Cell Ltd., Glycostem Therapeutics B.V., iCell Gene Therapeutics LLC, ImmunityBio, Inc. by NantWorks LLC, Innate Pharma S.A., Kiadis Pharma N.V. by Sanofi S.A., Merck KGaA, MiNK Therapeutics, Inc., Multimmune GmbH, Nkarta, Inc., PersonGen BioTherapeutics, Phio Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Natural Killer Cell Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Therapeutics
- NK Cell Directed Antibodies
- NK Cell Therapies
Approaches
- Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
- Bispecific Antibodies
Application
- Acute Infectious Diseases
- Cancer
- Gastrointestinal Diseases
- Immunoproliferative Disorders
End User
- Hospitals
- Research & Academic Institutes
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Natural Killer Cell Therapeutics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Natural Killer Cell Therapeutics Market?
What are the technology trends and regulatory frameworks in the Natural Killer Cell Therapeutics Market?
What is the market share of the leading vendors in the Natural Killer Cell Therapeutics Market?
Which modes and strategic moves are suitable for entering the Natural Killer Cell Therapeutics Market?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Natural Killer Cell Therapeutics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of cancer worldwide
5.1.1.2. Inclination towards targeted therapies with minimal side effects
5.1.1.3. Significant improvements in immunotherapy
5.1.2. Restraints
5.1.2.1. High cost associated with natural killer cell therapeutics
5.1.3. Opportunities
5.1.3.1. Ongoing R&D to improve natural killer cell therapeutics
5.1.3.2. Favorable investments for development of novel natural killer cell therapeutics
5.1.4. Challenges
5.1.4.1. Complexity associated with natural killer cell therapeutics
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Natural Killer Cell Therapeutics Market, by Therapeutics

6.1. Introduction
6.2. NK Cell Directed Antibodies
6.3. NK Cell Therapies

7. Natural Killer Cell Therapeutics Market, by Approaches

7.1. Introduction
7.2. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
7.3. Bispecific Antibodies

8. Natural Killer Cell Therapeutics Market, by Application

8.1. Introduction
8.2. Acute Infectious Diseases
8.3. Cancer
8.4. Gastrointestinal Diseases
8.5. Immunoproliferative Disorders

9. Natural Killer Cell Therapeutics Market, by End User

9.1. Introduction
9.2. Hospitals
9.3. Research & Academic Institutes
9.4. Specialty Clinics

10. Americas Natural Killer Cell Therapeutics Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Natural Killer Cell Therapeutics Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Natural Killer Cell Therapeutics Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Acepodia Inc.
14.1.2. Affimed N.V.
14.1.3. BioHaven Pharmaceutical Holding Company Ltd. by Pfizer Inc.
14.1.4. Celgene Corporation by Bristol-Myers Squibb Company
14.1.5. Celularity Inc.
14.1.6. Century Therapeutics, Inc.
14.1.7. Cytovac A/S
14.1.8. Dragonfly Therapeutics, Inc.
14.1.9. EMERcell
14.1.10. Fate Therapeutics, Inc.
14.1.11. Fortress Biotech, Inc.
14.1.12. Gamida Cell Ltd.
14.1.13. Glycostem Therapeutics B.V.
14.1.14. iCell Gene Therapeutics LLC
14.1.15. ImmunityBio, Inc. by NantWorks LLC
14.1.16. Innate Pharma S.A.
14.1.17. Kiadis Pharma N.V. by Sanofi S.A.
14.1.18. Merck KGaA
14.1.19. MiNK Therapeutics, Inc.
14.1.20. Multimmune GmbH
14.1.21. Nkarta, Inc.
14.1.22. PersonGen BioTherapeutics
14.1.23. Phio Pharmaceuticals Inc.
14.1.24. Regeneron Pharmaceuticals Inc.
14.1.25. Takeda Pharmaceutical Company Limited
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. NATURAL KILLER CELL THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NATURAL KILLER CELL THERAPEUTICS MARKET DYNAMICS
FIGURE 7. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2023 VS 2030 (%)
FIGURE 8. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2023 VS 2030 (%)
FIGURE 10. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. NATURAL KILLER CELL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. NATURAL KILLER CELL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. NATURAL KILLER CELL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 6. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY NK CELL DIRECTED ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY NK CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 9. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY BISPECIFIC ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ACUTE INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY IMMUNOPROLIFERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 34. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 35. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 38. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 39. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. CHINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 56. CHINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 57. CHINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. INDIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 60. INDIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 61. INDIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. JAPAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 68. JAPAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 69. JAPAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. THAILAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 92. THAILAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 93. THAILAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 105. DENMARK NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 106. DENMARK NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. DENMARK NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. EGYPT NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 109. EGYPT NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 110. EGYPT NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. FINLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 113. FINLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 114. FINLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 117. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 118. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 121. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 122. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. ITALY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 129. ITALY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 130. ITALY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. NORWAY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 141. NORWAY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 142. NORWAY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. POLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 145. POLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 146. POLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. QATAR NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 149. QATAR NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 150. QATAR NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 165. SPAIN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 166. SPAIN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. TURKEY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 177. TURKEY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 178. TURKEY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. NATURAL KILLER CELL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. NATURAL KILLER CELL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. NATURAL KILLER CELL THERAPEUTICS MARKET LICENSE & PRICING

Companies Mentioned

Acepodia Inc.
Affimed N.V.
BioHaven Pharmaceutical Holding Company Ltd. by Pfizer Inc.
Celgene Corporation by Bristol-Myers Squibb Company
Celularity Inc.
Century Therapeutics, Inc.
Cytovac A/S
Dragonfly Therapeutics, Inc.
EMERcell
Fate Therapeutics, Inc.
Fortress Biotech, Inc.
Gamida Cell Ltd.
Glycostem Therapeutics B.V.
iCell Gene Therapeutics LLC
ImmunityBio, Inc. by NantWorks LLC
Innate Pharma S.A.
Kiadis Pharma N.V. by Sanofi S.A.
Merck KGaA
MiNK Therapeutics, Inc.
Multimmune GmbH
Nkarta, Inc.
PersonGen BioTherapeutics
Phio Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Takeda Pharmaceutical Company Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 6.02 Billion
Forecasted Market Value ( USD ) by 2030	$ 11.71 Billion
Compound Annual Growth Rate	11.9%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Natural Killer Cells Therapeutics Market by Therapeutics, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2027

Natural Killer Cell Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

Global Natural Killer Cells Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

NK Cell therapies - Pipeline Insight, 2024

iPSC derived NK cells - Pipeline Insight, 2024